nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.054	0.0879	CbGbCtD
Rifaximin—CYP3A4—Felbamate—epilepsy syndrome	0.0502	0.0817	CbGbCtD
Rifaximin—CYP3A4—Trimethadione—epilepsy syndrome	0.0502	0.0817	CbGbCtD
Rifaximin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0472	0.0768	CbGbCtD
Rifaximin—CYP3A4—Clonazepam—epilepsy syndrome	0.0427	0.0695	CbGbCtD
Rifaximin—CYP3A4—Clobazam—epilepsy syndrome	0.0409	0.0666	CbGbCtD
Rifaximin—CYP3A4—Rufinamide—epilepsy syndrome	0.0348	0.0566	CbGbCtD
Rifaximin—CYP3A4—Carbamazepine—epilepsy syndrome	0.0339	0.0552	CbGbCtD
Rifaximin—CYP3A4—Primidone—epilepsy syndrome	0.0317	0.0515	CbGbCtD
Rifaximin—CYP3A4—Phenytoin—epilepsy syndrome	0.0304	0.0495	CbGbCtD
Rifaximin—CYP3A4—Propofol—epilepsy syndrome	0.0284	0.0462	CbGbCtD
Rifaximin—CYP3A4—Acetazolamide—epilepsy syndrome	0.0271	0.0441	CbGbCtD
Rifaximin—CYP3A4—Phenobarbital—epilepsy syndrome	0.0271	0.0441	CbGbCtD
Rifaximin—CYP3A4—Midazolam—epilepsy syndrome	0.0267	0.0435	CbGbCtD
Rifaximin—CYP3A4—Diazepam—epilepsy syndrome	0.0257	0.0418	CbGbCtD
Rifaximin—CYP3A4—Zonisamide—epilepsy syndrome	0.0251	0.0408	CbGbCtD
Rifaximin—CYP3A4—Valproic Acid—epilepsy syndrome	0.0203	0.033	CbGbCtD
Rifaximin—CYP3A4—Topiramate—epilepsy syndrome	0.0183	0.0297	CbGbCtD
Rifaximin—Rifampicin—SLCO1A2—epilepsy syndrome	0.00211	0.42	CrCbGaD
Rifaximin—Rifampicin—ABCC2—epilepsy syndrome	0.00101	0.201	CrCbGaD
Rifaximin—Rifapentine—CYP2D6—epilepsy syndrome	0.000834	0.166	CrCbGaD
Rifaximin—Rifampicin—CYP2C19—epilepsy syndrome	0.000702	0.14	CrCbGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.000685	0.134	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	0.000393	0.0769	CbGpPWpGaD
Rifaximin—Rifampicin—ABCB1—epilepsy syndrome	0.000372	0.0739	CrCbGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	0.000364	0.0711	CbGpPWpGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000363	0.0709	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	0.000209	0.0408	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	0.000208	0.0407	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—VDR—epilepsy syndrome	0.000191	0.0373	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR3C1—epilepsy syndrome	0.000172	0.0335	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	0.000151	0.0294	CbGpPWpGaD
Rifaximin—CYP3A4—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.000145	0.0283	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR3C1—epilepsy syndrome	0.000136	0.0265	CbGpPWpGaD
Rifaximin—Back pain—Gabapentin—epilepsy syndrome	0.000124	0.00033	CcSEcCtD
Rifaximin—Headache—Fosphenytoin—epilepsy syndrome	0.000124	0.00033	CcSEcCtD
Rifaximin—Haemorrhage—Topiramate—epilepsy syndrome	0.000124	0.00033	CcSEcCtD
Rifaximin—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000124	0.00033	CcSEcCtD
Rifaximin—Asthenia—Phenytoin—epilepsy syndrome	0.000123	0.000329	CcSEcCtD
Rifaximin—Nausea—Midazolam—epilepsy syndrome	0.000123	0.000328	CcSEcCtD
Rifaximin—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000123	0.000328	CcSEcCtD
Rifaximin—Muscle spasms—Gabapentin—epilepsy syndrome	0.000123	0.000328	CcSEcCtD
Rifaximin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000123	0.000328	CcSEcCtD
Rifaximin—Pharyngitis—Topiramate—epilepsy syndrome	0.000123	0.000327	CcSEcCtD
Rifaximin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000123	0.000327	CcSEcCtD
Rifaximin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000123	0.000327	CcSEcCtD
Rifaximin—Pruritus—Clonazepam—epilepsy syndrome	0.000122	0.000327	CcSEcCtD
Rifaximin—Vomiting—Vigabatrin—epilepsy syndrome	0.000122	0.000326	CcSEcCtD
Rifaximin—Skin disorder—Valproic Acid—epilepsy syndrome	0.000122	0.000326	CcSEcCtD
Rifaximin—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000122	0.000326	CcSEcCtD
Rifaximin—Oedema peripheral—Topiramate—epilepsy syndrome	0.000122	0.000325	CcSEcCtD
Rifaximin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000122	0.000325	CcSEcCtD
Rifaximin—Cough—Pregabalin—epilepsy syndrome	0.000122	0.000325	CcSEcCtD
Rifaximin—Pruritus—Phenytoin—epilepsy syndrome	0.000122	0.000324	CcSEcCtD
Rifaximin—Nausea—Levetiracetam—epilepsy syndrome	0.000122	0.000324	CcSEcCtD
Rifaximin—Rash—Vigabatrin—epilepsy syndrome	0.000121	0.000324	CcSEcCtD
Rifaximin—Dizziness—Felbamate—epilepsy syndrome	0.000121	0.000323	CcSEcCtD
Rifaximin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000121	0.000323	CcSEcCtD
Rifaximin—Urethral disorder—Topiramate—epilepsy syndrome	0.000121	0.000323	CcSEcCtD
Rifaximin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000121	0.000323	CcSEcCtD
Rifaximin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000121	0.000322	CcSEcCtD
Rifaximin—Headache—Vigabatrin—epilepsy syndrome	0.000121	0.000322	CcSEcCtD
Rifaximin—Vomiting—Diazepam—epilepsy syndrome	0.000121	0.000321	CcSEcCtD
Rifaximin—Anorexia—Valproic Acid—epilepsy syndrome	0.00012	0.00032	CcSEcCtD
Rifaximin—Tremor—Gabapentin—epilepsy syndrome	0.00012	0.00032	CcSEcCtD
Rifaximin—Rash—Diazepam—epilepsy syndrome	0.00012	0.000319	CcSEcCtD
Rifaximin—Dermatitis—Diazepam—epilepsy syndrome	0.000119	0.000318	CcSEcCtD
Rifaximin—Myalgia—Pregabalin—epilepsy syndrome	0.000119	0.000317	CcSEcCtD
Rifaximin—Arthralgia—Pregabalin—epilepsy syndrome	0.000119	0.000317	CcSEcCtD
Rifaximin—Chest pain—Pregabalin—epilepsy syndrome	0.000119	0.000317	CcSEcCtD
Rifaximin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000119	0.000317	CcSEcCtD
Rifaximin—Dizziness—Zonisamide—epilepsy syndrome	0.000119	0.000317	CcSEcCtD
Rifaximin—Headache—Diazepam—epilepsy syndrome	0.000119	0.000317	CcSEcCtD
Rifaximin—Diarrhoea—Clonazepam—epilepsy syndrome	0.000118	0.000316	CcSEcCtD
Rifaximin—Anaemia—Gabapentin—epilepsy syndrome	0.000118	0.000315	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000118	0.000315	CcSEcCtD
Rifaximin—Hypotension—Valproic Acid—epilepsy syndrome	0.000118	0.000314	CcSEcCtD
Rifaximin—Asthenia—Carbamazepine—epilepsy syndrome	0.000118	0.000314	CcSEcCtD
Rifaximin—Diarrhoea—Phenytoin—epilepsy syndrome	0.000118	0.000314	CcSEcCtD
Rifaximin—Discomfort—Pregabalin—epilepsy syndrome	0.000117	0.000313	CcSEcCtD
Rifaximin—Nausea—Fosphenytoin—epilepsy syndrome	0.000117	0.000313	CcSEcCtD
Rifaximin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000117	0.000312	CcSEcCtD
Rifaximin—Angioedema—Gabapentin—epilepsy syndrome	0.000117	0.000312	CcSEcCtD
Rifaximin—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000117	0.000312	CcSEcCtD
Rifaximin—Vomiting—Felbamate—epilepsy syndrome	0.000117	0.000311	CcSEcCtD
Rifaximin—Dry mouth—Pregabalin—epilepsy syndrome	0.000116	0.00031	CcSEcCtD
Rifaximin—Pruritus—Carbamazepine—epilepsy syndrome	0.000116	0.00031	CcSEcCtD
Rifaximin—Rash—Felbamate—epilepsy syndrome	0.000116	0.000308	CcSEcCtD
Rifaximin—Dermatitis—Felbamate—epilepsy syndrome	0.000116	0.000308	CcSEcCtD
Rifaximin—Malaise—Gabapentin—epilepsy syndrome	0.000115	0.000308	CcSEcCtD
Rifaximin—Tinnitus—Topiramate—epilepsy syndrome	0.000115	0.000308	CcSEcCtD
Rifaximin—Vertigo—Gabapentin—epilepsy syndrome	0.000115	0.000307	CcSEcCtD
Rifaximin—Headache—Felbamate—epilepsy syndrome	0.000115	0.000306	CcSEcCtD
Rifaximin—Confusional state—Pregabalin—epilepsy syndrome	0.000115	0.000306	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000115	0.000306	CcSEcCtD
Rifaximin—Flushing—Topiramate—epilepsy syndrome	0.000115	0.000306	CcSEcCtD
Rifaximin—Syncope—Gabapentin—epilepsy syndrome	0.000115	0.000306	CcSEcCtD
Rifaximin—Dizziness—Clonazepam—epilepsy syndrome	0.000114	0.000305	CcSEcCtD
Rifaximin—Nausea—Vigabatrin—epilepsy syndrome	0.000114	0.000305	CcSEcCtD
Rifaximin—Vomiting—Zonisamide—epilepsy syndrome	0.000114	0.000304	CcSEcCtD
Rifaximin—Insomnia—Valproic Acid—epilepsy syndrome	0.000114	0.000304	CcSEcCtD
Rifaximin—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000114	0.000304	CcSEcCtD
Rifaximin—Asthenia—Lamotrigine—epilepsy syndrome	0.000114	0.000303	CcSEcCtD
Rifaximin—Dizziness—Phenytoin—epilepsy syndrome	0.000114	0.000303	CcSEcCtD
Rifaximin—Rash—Zonisamide—epilepsy syndrome	0.000113	0.000302	CcSEcCtD
Rifaximin—Infection—Pregabalin—epilepsy syndrome	0.000113	0.000302	CcSEcCtD
Rifaximin—Dermatitis—Zonisamide—epilepsy syndrome	0.000113	0.000302	CcSEcCtD
Rifaximin—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000113	0.000302	CcSEcCtD
Rifaximin—Nausea—Diazepam—epilepsy syndrome	0.000113	0.0003	CcSEcCtD
Rifaximin—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000113	0.0003	CcSEcCtD
Rifaximin—Headache—Zonisamide—epilepsy syndrome	0.000113	0.0003	CcSEcCtD
Rifaximin—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000112	0.0003	CcSEcCtD
Rifaximin—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000112	0.000299	CcSEcCtD
Rifaximin—Angiopathy—Topiramate—epilepsy syndrome	0.000112	0.000299	CcSEcCtD
Rifaximin—Pruritus—Lamotrigine—epilepsy syndrome	0.000112	0.000299	CcSEcCtD
Rifaximin—Shock—Pregabalin—epilepsy syndrome	0.000112	0.000299	CcSEcCtD
Rifaximin—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000112	0.000298	CcSEcCtD
Rifaximin—Cough—Gabapentin—epilepsy syndrome	0.000112	0.000298	CcSEcCtD
Rifaximin—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000112	0.000297	CcSEcCtD
Rifaximin—Skin disorder—Pregabalin—epilepsy syndrome	0.000111	0.000295	CcSEcCtD
Rifaximin—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.00011	0.000294	CcSEcCtD
Rifaximin—Vomiting—Clonazepam—epilepsy syndrome	0.00011	0.000293	CcSEcCtD
Rifaximin—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00011	0.000292	CcSEcCtD
Rifaximin—Vomiting—Phenytoin—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Rash—Clonazepam—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Dermatitis—Clonazepam—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Arthralgia—Gabapentin—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Chest pain—Gabapentin—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Myalgia—Gabapentin—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Nausea—Felbamate—epilepsy syndrome	0.000109	0.000291	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000109	0.00029	CcSEcCtD
Rifaximin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000109	0.00029	CcSEcCtD
Rifaximin—Fatigue—Valproic Acid—epilepsy syndrome	0.000109	0.00029	CcSEcCtD
Rifaximin—Anorexia—Pregabalin—epilepsy syndrome	0.000109	0.00029	CcSEcCtD
Rifaximin—Dizziness—Carbamazepine—epilepsy syndrome	0.000109	0.000289	CcSEcCtD
Rifaximin—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000109	0.000289	CcSEcCtD
Rifaximin—Headache—Clonazepam—epilepsy syndrome	0.000108	0.000289	CcSEcCtD
Rifaximin—Rash—Phenytoin—epilepsy syndrome	0.000108	0.000289	CcSEcCtD
Rifaximin—Mental disorder—Topiramate—epilepsy syndrome	0.000108	0.000289	CcSEcCtD
Rifaximin—Dermatitis—Phenytoin—epilepsy syndrome	0.000108	0.000289	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000108	0.000289	CcSEcCtD
Rifaximin—Rash—Oxcarbazepine—epilepsy syndrome	0.000108	0.000288	CcSEcCtD
Rifaximin—Pain—Valproic Acid—epilepsy syndrome	0.000108	0.000287	CcSEcCtD
Rifaximin—Constipation—Valproic Acid—epilepsy syndrome	0.000108	0.000287	CcSEcCtD
Rifaximin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000108	0.000287	CcSEcCtD
Rifaximin—Headache—Phenytoin—epilepsy syndrome	0.000108	0.000287	CcSEcCtD
Rifaximin—Malnutrition—Topiramate—epilepsy syndrome	0.000108	0.000287	CcSEcCtD
Rifaximin—Discomfort—Gabapentin—epilepsy syndrome	0.000108	0.000287	CcSEcCtD
Rifaximin—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.000108	0.021	CbGpPWpGaD
Rifaximin—Headache—Oxcarbazepine—epilepsy syndrome	0.000107	0.000286	CcSEcCtD
Rifaximin—Nausea—Zonisamide—epilepsy syndrome	0.000107	0.000284	CcSEcCtD
Rifaximin—Dry mouth—Gabapentin—epilepsy syndrome	0.000107	0.000284	CcSEcCtD
Rifaximin—Hypotension—Pregabalin—epilepsy syndrome	0.000106	0.000284	CcSEcCtD
Rifaximin—Flatulence—Topiramate—epilepsy syndrome	0.000106	0.000283	CcSEcCtD
Rifaximin—Confusional state—Gabapentin—epilepsy syndrome	0.000105	0.000281	CcSEcCtD
Rifaximin—Dizziness—Lamotrigine—epilepsy syndrome	0.000105	0.00028	CcSEcCtD
Rifaximin—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000105	0.000279	CcSEcCtD
Rifaximin—Vomiting—Carbamazepine—epilepsy syndrome	0.000104	0.000278	CcSEcCtD
Rifaximin—Back pain—Topiramate—epilepsy syndrome	0.000104	0.000278	CcSEcCtD
Rifaximin—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000104	0.000277	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000104	0.000277	CcSEcCtD
Rifaximin—Infection—Gabapentin—epilepsy syndrome	0.000104	0.000277	CcSEcCtD
Rifaximin—Muscle spasms—Topiramate—epilepsy syndrome	0.000104	0.000276	CcSEcCtD
Rifaximin—Rash—Carbamazepine—epilepsy syndrome	0.000103	0.000276	CcSEcCtD
Rifaximin—Dermatitis—Carbamazepine—epilepsy syndrome	0.000103	0.000276	CcSEcCtD
Rifaximin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000103	0.000275	CcSEcCtD
Rifaximin—Insomnia—Pregabalin—epilepsy syndrome	0.000103	0.000275	CcSEcCtD
Rifaximin—Nausea—Clonazepam—epilepsy syndrome	0.000103	0.000274	CcSEcCtD
Rifaximin—Headache—Carbamazepine—epilepsy syndrome	0.000103	0.000274	CcSEcCtD
Rifaximin—Shock—Gabapentin—epilepsy syndrome	0.000103	0.000274	CcSEcCtD
Rifaximin—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000102	0.000273	CcSEcCtD
Rifaximin—Nausea—Phenytoin—epilepsy syndrome	0.000102	0.000272	CcSEcCtD
Rifaximin—Dyspnoea—Pregabalin—epilepsy syndrome	0.000102	0.000271	CcSEcCtD
Rifaximin—Nausea—Oxcarbazepine—epilepsy syndrome	0.000102	0.000271	CcSEcCtD
Rifaximin—Skin disorder—Gabapentin—epilepsy syndrome	0.000102	0.000271	CcSEcCtD
Rifaximin—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000101	0.000269	CcSEcCtD
Rifaximin—Tremor—Topiramate—epilepsy syndrome	0.000101	0.000269	CcSEcCtD
Rifaximin—Vomiting—Lamotrigine—epilepsy syndrome	0.000101	0.000269	CcSEcCtD
Rifaximin—Urticaria—Valproic Acid—epilepsy syndrome	0.0001	0.000267	CcSEcCtD
Rifaximin—Rash—Lamotrigine—epilepsy syndrome	0.0001	0.000267	CcSEcCtD
Rifaximin—Ill-defined disorder—Topiramate—epilepsy syndrome	0.0001	0.000266	CcSEcCtD
Rifaximin—Dermatitis—Lamotrigine—epilepsy syndrome	9.99e-05	0.000266	CcSEcCtD
Rifaximin—Body temperature increased—Valproic Acid—epilepsy syndrome	9.97e-05	0.000266	CcSEcCtD
Rifaximin—Abdominal pain—Valproic Acid—epilepsy syndrome	9.97e-05	0.000266	CcSEcCtD
Rifaximin—Anorexia—Gabapentin—epilepsy syndrome	9.96e-05	0.000266	CcSEcCtD
Rifaximin—Anaemia—Topiramate—epilepsy syndrome	9.96e-05	0.000265	CcSEcCtD
Rifaximin—Headache—Lamotrigine—epilepsy syndrome	9.94e-05	0.000265	CcSEcCtD
Rifaximin—Decreased appetite—Pregabalin—epilepsy syndrome	9.91e-05	0.000264	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	9.84e-05	0.000262	CcSEcCtD
Rifaximin—Fatigue—Pregabalin—epilepsy syndrome	9.83e-05	0.000262	CcSEcCtD
Rifaximin—Hypotension—Gabapentin—epilepsy syndrome	9.77e-05	0.00026	CcSEcCtD
Rifaximin—Nausea—Carbamazepine—epilepsy syndrome	9.75e-05	0.00026	CcSEcCtD
Rifaximin—Constipation—Pregabalin—epilepsy syndrome	9.75e-05	0.00026	CcSEcCtD
Rifaximin—Pain—Pregabalin—epilepsy syndrome	9.75e-05	0.00026	CcSEcCtD
Rifaximin—Malaise—Topiramate—epilepsy syndrome	9.71e-05	0.000259	CcSEcCtD
Rifaximin—Vertigo—Topiramate—epilepsy syndrome	9.68e-05	0.000258	CcSEcCtD
Rifaximin—Syncope—Topiramate—epilepsy syndrome	9.66e-05	0.000258	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	9.52e-05	0.000254	CcSEcCtD
Rifaximin—Loss of consciousness—Topiramate—epilepsy syndrome	9.47e-05	0.000252	CcSEcCtD
Rifaximin—Insomnia—Gabapentin—epilepsy syndrome	9.45e-05	0.000252	CcSEcCtD
Rifaximin—Nausea—Lamotrigine—epilepsy syndrome	9.42e-05	0.000251	CcSEcCtD
Rifaximin—Cough—Topiramate—epilepsy syndrome	9.4e-05	0.000251	CcSEcCtD
Rifaximin—Feeling abnormal—Pregabalin—epilepsy syndrome	9.39e-05	0.00025	CcSEcCtD
Rifaximin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	9.32e-05	0.000248	CcSEcCtD
Rifaximin—Dyspnoea—Gabapentin—epilepsy syndrome	9.32e-05	0.000248	CcSEcCtD
Rifaximin—Hypersensitivity—Valproic Acid—epilepsy syndrome	9.29e-05	0.000248	CcSEcCtD
Rifaximin—CYP3A4—Irinotecan Pathway—ABCC2—epilepsy syndrome	9.26e-05	0.0181	CbGpPWpGaD
Rifaximin—Myalgia—Topiramate—epilepsy syndrome	9.17e-05	0.000244	CcSEcCtD
Rifaximin—Chest pain—Topiramate—epilepsy syndrome	9.17e-05	0.000244	CcSEcCtD
Rifaximin—Arthralgia—Topiramate—epilepsy syndrome	9.17e-05	0.000244	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.11e-05	0.000243	CcSEcCtD
Rifaximin—Decreased appetite—Gabapentin—epilepsy syndrome	9.08e-05	0.000242	CcSEcCtD
Rifaximin—Discomfort—Topiramate—epilepsy syndrome	9.06e-05	0.000242	CcSEcCtD
Rifaximin—Urticaria—Pregabalin—epilepsy syndrome	9.05e-05	0.000241	CcSEcCtD
Rifaximin—Asthenia—Valproic Acid—epilepsy syndrome	9.04e-05	0.000241	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.02e-05	0.000241	CcSEcCtD
Rifaximin—Fatigue—Gabapentin—epilepsy syndrome	9.01e-05	0.00024	CcSEcCtD
Rifaximin—Abdominal pain—Pregabalin—epilepsy syndrome	9.01e-05	0.00024	CcSEcCtD
Rifaximin—Body temperature increased—Pregabalin—epilepsy syndrome	9.01e-05	0.00024	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—WARS—epilepsy syndrome	8.98e-05	0.0175	CbGpPWpGaD
Rifaximin—Dry mouth—Topiramate—epilepsy syndrome	8.97e-05	0.000239	CcSEcCtD
Rifaximin—Pain—Gabapentin—epilepsy syndrome	8.94e-05	0.000238	CcSEcCtD
Rifaximin—Constipation—Gabapentin—epilepsy syndrome	8.94e-05	0.000238	CcSEcCtD
Rifaximin—Pruritus—Valproic Acid—epilepsy syndrome	8.92e-05	0.000238	CcSEcCtD
Rifaximin—Confusional state—Topiramate—epilepsy syndrome	8.87e-05	0.000236	CcSEcCtD
Rifaximin—Infection—Topiramate—epilepsy syndrome	8.73e-05	0.000233	CcSEcCtD
Rifaximin—Shock—Topiramate—epilepsy syndrome	8.65e-05	0.000231	CcSEcCtD
Rifaximin—Diarrhoea—Valproic Acid—epilepsy syndrome	8.63e-05	0.00023	CcSEcCtD
Rifaximin—Nervous system disorder—Topiramate—epilepsy syndrome	8.62e-05	0.00023	CcSEcCtD
Rifaximin—Feeling abnormal—Gabapentin—epilepsy syndrome	8.61e-05	0.00023	CcSEcCtD
Rifaximin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	8.55e-05	0.000228	CcSEcCtD
Rifaximin—Skin disorder—Topiramate—epilepsy syndrome	8.54e-05	0.000228	CcSEcCtD
Rifaximin—Hyperhidrosis—Topiramate—epilepsy syndrome	8.5e-05	0.000227	CcSEcCtD
Rifaximin—Hypersensitivity—Pregabalin—epilepsy syndrome	8.4e-05	0.000224	CcSEcCtD
Rifaximin—Anorexia—Topiramate—epilepsy syndrome	8.38e-05	0.000223	CcSEcCtD
Rifaximin—Dizziness—Valproic Acid—epilepsy syndrome	8.34e-05	0.000222	CcSEcCtD
Rifaximin—Urticaria—Gabapentin—epilepsy syndrome	8.3e-05	0.000221	CcSEcCtD
Rifaximin—Abdominal pain—Gabapentin—epilepsy syndrome	8.26e-05	0.00022	CcSEcCtD
Rifaximin—Body temperature increased—Gabapentin—epilepsy syndrome	8.26e-05	0.00022	CcSEcCtD
Rifaximin—Hypotension—Topiramate—epilepsy syndrome	8.22e-05	0.000219	CcSEcCtD
Rifaximin—Asthenia—Pregabalin—epilepsy syndrome	8.18e-05	0.000218	CcSEcCtD
Rifaximin—Pruritus—Pregabalin—epilepsy syndrome	8.06e-05	0.000215	CcSEcCtD
Rifaximin—Vomiting—Valproic Acid—epilepsy syndrome	8.02e-05	0.000214	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.01e-05	0.000214	CcSEcCtD
Rifaximin—Insomnia—Topiramate—epilepsy syndrome	7.95e-05	0.000212	CcSEcCtD
Rifaximin—Rash—Valproic Acid—epilepsy syndrome	7.95e-05	0.000212	CcSEcCtD
Rifaximin—Dermatitis—Valproic Acid—epilepsy syndrome	7.94e-05	0.000212	CcSEcCtD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	7.92e-05	0.0155	CbGpPWpGaD
Rifaximin—Headache—Valproic Acid—epilepsy syndrome	7.9e-05	0.000211	CcSEcCtD
Rifaximin—CYP3A4—Irinotecan Pathway—ABCG2—epilepsy syndrome	7.87e-05	0.0154	CbGpPWpGaD
Rifaximin—Dyspnoea—Topiramate—epilepsy syndrome	7.84e-05	0.000209	CcSEcCtD
Rifaximin—Diarrhoea—Pregabalin—epilepsy syndrome	7.8e-05	0.000208	CcSEcCtD
Rifaximin—Hypersensitivity—Gabapentin—epilepsy syndrome	7.7e-05	0.000205	CcSEcCtD
Rifaximin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	7.69e-05	0.015	CbGpPWpGaD
Rifaximin—Decreased appetite—Topiramate—epilepsy syndrome	7.64e-05	0.000204	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	7.59e-05	0.000202	CcSEcCtD
Rifaximin—Fatigue—Topiramate—epilepsy syndrome	7.58e-05	0.000202	CcSEcCtD
Rifaximin—Dizziness—Pregabalin—epilepsy syndrome	7.54e-05	0.000201	CcSEcCtD
Rifaximin—Constipation—Topiramate—epilepsy syndrome	7.52e-05	0.0002	CcSEcCtD
Rifaximin—Pain—Topiramate—epilepsy syndrome	7.52e-05	0.0002	CcSEcCtD
Rifaximin—Asthenia—Gabapentin—epilepsy syndrome	7.5e-05	0.0002	CcSEcCtD
Rifaximin—Nausea—Valproic Acid—epilepsy syndrome	7.49e-05	0.0002	CcSEcCtD
Rifaximin—Pruritus—Gabapentin—epilepsy syndrome	7.39e-05	0.000197	CcSEcCtD
Rifaximin—Vomiting—Pregabalin—epilepsy syndrome	7.25e-05	0.000193	CcSEcCtD
Rifaximin—Feeling abnormal—Topiramate—epilepsy syndrome	7.25e-05	0.000193	CcSEcCtD
Rifaximin—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.19e-05	0.000192	CcSEcCtD
Rifaximin—Rash—Pregabalin—epilepsy syndrome	7.19e-05	0.000192	CcSEcCtD
Rifaximin—Dermatitis—Pregabalin—epilepsy syndrome	7.18e-05	0.000191	CcSEcCtD
Rifaximin—Diarrhoea—Gabapentin—epilepsy syndrome	7.15e-05	0.000191	CcSEcCtD
Rifaximin—Headache—Pregabalin—epilepsy syndrome	7.14e-05	0.00019	CcSEcCtD
Rifaximin—Urticaria—Topiramate—epilepsy syndrome	6.98e-05	0.000186	CcSEcCtD
Rifaximin—Abdominal pain—Topiramate—epilepsy syndrome	6.95e-05	0.000185	CcSEcCtD
Rifaximin—Body temperature increased—Topiramate—epilepsy syndrome	6.95e-05	0.000185	CcSEcCtD
Rifaximin—Dizziness—Gabapentin—epilepsy syndrome	6.91e-05	0.000184	CcSEcCtD
Rifaximin—Nausea—Pregabalin—epilepsy syndrome	6.77e-05	0.00018	CcSEcCtD
Rifaximin—Vomiting—Gabapentin—epilepsy syndrome	6.64e-05	0.000177	CcSEcCtD
Rifaximin—Rash—Gabapentin—epilepsy syndrome	6.59e-05	0.000176	CcSEcCtD
Rifaximin—Dermatitis—Gabapentin—epilepsy syndrome	6.58e-05	0.000175	CcSEcCtD
Rifaximin—Headache—Gabapentin—epilepsy syndrome	6.55e-05	0.000175	CcSEcCtD
Rifaximin—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	6.52e-05	0.0127	CbGpPWpGaD
Rifaximin—Hypersensitivity—Topiramate—epilepsy syndrome	6.48e-05	0.000173	CcSEcCtD
Rifaximin—Asthenia—Topiramate—epilepsy syndrome	6.31e-05	0.000168	CcSEcCtD
Rifaximin—Pruritus—Topiramate—epilepsy syndrome	6.22e-05	0.000166	CcSEcCtD
Rifaximin—Nausea—Gabapentin—epilepsy syndrome	6.21e-05	0.000165	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	6.18e-05	0.0121	CbGpPWpGaD
Rifaximin—Diarrhoea—Topiramate—epilepsy syndrome	6.02e-05	0.00016	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—WARS—epilepsy syndrome	5.94e-05	0.0116	CbGpPWpGaD
Rifaximin—Dizziness—Topiramate—epilepsy syndrome	5.81e-05	0.000155	CcSEcCtD
Rifaximin—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	5.77e-05	0.0113	CbGpPWpGaD
Rifaximin—Vomiting—Topiramate—epilepsy syndrome	5.59e-05	0.000149	CcSEcCtD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	5.55e-05	0.0108	CbGpPWpGaD
Rifaximin—Rash—Topiramate—epilepsy syndrome	5.54e-05	0.000148	CcSEcCtD
Rifaximin—Dermatitis—Topiramate—epilepsy syndrome	5.54e-05	0.000148	CcSEcCtD
Rifaximin—Headache—Topiramate—epilepsy syndrome	5.51e-05	0.000147	CcSEcCtD
Rifaximin—Nausea—Topiramate—epilepsy syndrome	5.22e-05	0.000139	CcSEcCtD
Rifaximin—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	5.17e-05	0.0101	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	4.97e-05	0.00972	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	4.78e-05	0.00934	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	4.55e-05	0.0089	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—QARS—epilepsy syndrome	4.5e-05	0.0088	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	4.21e-05	0.00822	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	4.2e-05	0.0082	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	4.18e-05	0.00817	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	3.96e-05	0.00774	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EIF2B5—epilepsy syndrome	3.6e-05	0.00704	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—JUNB—epilepsy syndrome	3.28e-05	0.00641	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—TFAM—epilepsy syndrome	3.26e-05	0.00636	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	3.08e-05	0.00602	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SNRPE—epilepsy syndrome	2.81e-05	0.00549	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—VDR—epilepsy syndrome	2.6e-05	0.00509	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	2.54e-05	0.00495	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	2.42e-05	0.00472	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	2.41e-05	0.00471	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	2.39e-05	0.00468	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	2.38e-05	0.00465	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	2.36e-05	0.00462	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	2.35e-05	0.00459	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR3C1—epilepsy syndrome	2.34e-05	0.00458	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	2.15e-05	0.0042	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	2.12e-05	0.00414	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EIF2S1—epilepsy syndrome	1.96e-05	0.00383	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	1.95e-05	0.00381	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	1.94e-05	0.00379	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	1.93e-05	0.00377	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HSPB1—epilepsy syndrome	1.89e-05	0.0037	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	1.74e-05	0.0034	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—JUNB—epilepsy syndrome	1.58e-05	0.00309	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SIRT1—epilepsy syndrome	1.27e-05	0.00248	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—VDR—epilepsy syndrome	1.25e-05	0.00245	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—H2AFX—epilepsy syndrome	1.19e-05	0.00232	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—YWHAZ—epilepsy syndrome	1.15e-05	0.00224	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR3C1—epilepsy syndrome	1.13e-05	0.0022	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.05e-05	0.00206	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.03e-05	0.00202	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.02e-05	0.002	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.02e-05	0.00199	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.01e-05	0.00198	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	9.25e-06	0.00181	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	9.12e-06	0.00178	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	8.53e-06	0.00167	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA13—epilepsy syndrome	7.05e-06	0.00138	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	5.34e-06	0.00104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PDXK—epilepsy syndrome	5.34e-06	0.00104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CERS1—epilepsy syndrome	5.34e-06	0.00104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FAR1—epilepsy syndrome	5.34e-06	0.00104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADK—epilepsy syndrome	5.34e-06	0.00104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	5.34e-06	0.00104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.89e-06	0.000955	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.89e-06	0.000955	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.89e-06	0.000955	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.89e-06	0.000955	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.54e-06	0.000888	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.54e-06	0.000888	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.53e-06	0.000885	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COX3—epilepsy syndrome	4.27e-06	0.000835	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	4.05e-06	0.000792	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	4.05e-06	0.000792	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	4.05e-06	0.000792	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	4.05e-06	0.000792	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	4.05e-06	0.000792	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.7e-06	0.000724	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.7e-06	0.000724	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.7e-06	0.000724	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.57e-06	0.000697	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AKT1—epilepsy syndrome	3.45e-06	0.000675	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.44e-06	0.000673	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.44e-06	0.000673	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	3.24e-06	0.000633	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	3.15e-06	0.000616	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.07e-06	0.0006	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	3.07e-06	0.0006	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.93e-06	0.000572	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.93e-06	0.000572	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.87e-06	0.00056	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.81e-06	0.000549	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.75e-06	0.000538	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.7e-06	0.000528	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.53e-06	0.000494	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.45e-06	0.00048	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.22e-06	0.000434	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.22e-06	0.000434	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.81e-06	0.000354	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.76e-06	0.000345	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.75e-06	0.000342	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.58e-06	0.000309	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.51e-06	0.000294	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.5e-06	0.000293	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.43e-06	0.00028	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.41e-06	0.000276	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.41e-06	0.000275	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.18e-06	0.00023	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.16e-06	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.13e-06	0.000221	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.05e-06	0.000205	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.2e-07	0.00018	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.02e-07	0.000176	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.75e-07	0.000151	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.06e-07	0.000138	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.18e-07	0.000121	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.11e-07	6.07e-05	CbGpPWpGaD
